Properties of the COPD assessment test in a cross-sectional European study - PubMed (original) (raw)
Properties of the COPD assessment test in a cross-sectional European study
P W Jones et al. Eur Respir J. 2011 Jul.
Free article
Erratum in
- Eur Respir J. 2012 Jan;39(1):230
Abstract
A short, easy-to-use health status questionnaire is needed in the multidimensional assessment of chronic obstructive pulmonary disease (COPD) in routine practice. The performance of the eight-item COPD assessment test (CAT) was analysed in 1,817 patients from primary care in seven European countries. The CAT has a scoring range of 0-40 (high score representing poor health status). Mean CAT scores indicated significant health status impairment that was related to severity of airway obstruction, but within each Global Initiative for Obstructive Lung Disease stage (I to IV) there was a wide range of scores (I: 16.2 ± 8.8; II: 16.3 ± 7.9; III: 19.3 ± 8.2; and IV: 22.3 ± 8.7; I versus II, p = 0.88; II versus III, p<0.0001; III versus IV, p = 0.0001). CAT scores showed relatively little variability across countries (within ± 12% of the mean across all countries). Scores were significantly better in patients who were stable (17.2 ± 8.3) versus those suffering an exacerbation (21.3 ± 8.4) (p<0.0001); and in patients with no (17.3 ± 8.1) or one or two (16.6 ± 8.2) versus three or more (19.7 ± 8.5) comorbidities (p<0.0001 for both). The CAT distinguished between classes of other impairment measures and was strongly correlated with the St George's Respiratory Questionnaire (r = 0.8, p<0.0001). The CAT is a simple and easy-to-use questionnaire that distinguishes between patients of different degrees of COPD severity and appears to behave the same way across countries.
Similar articles
- COPD assessment test (CAT): simple tool for evaluating quality of life of chemical warfare patients with chronic obstructive pulmonary disease.
Lari SM, Ghobadi H, Attaran D, Mahmoodpour A, Shadkam O, Rostami M. Lari SM, et al. Clin Respir J. 2014 Jan;8(1):116-23. doi: 10.1111/crj.12047. Epub 2013 Nov 5. Clin Respir J. 2014. PMID: 23910892 - Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease.
Nagata K, Tomii K, Otsuka K, Tachikawa R, Otsuka K, Takeshita J, Tanaka K, Matsumoto T, Monden K. Nagata K, et al. Respirology. 2012 Apr;17(3):506-12. doi: 10.1111/j.1440-1843.2012.02131.x. Respirology. 2012. PMID: 22257381 - Validation of the COPD severity score for use in primary care: the NEREA study.
Miravitlles M, Llor C, de Castellar R, Izquierdo I, Baró E, Donado E. Miravitlles M, et al. Eur Respir J. 2009 Mar;33(3):519-27. doi: 10.1183/09031936.00087208. Epub 2009 Jan 22. Eur Respir J. 2009. PMID: 19164354 - Measuring the effects of COPD on the patient.
Jones P, Lareau S, Mahler DA. Jones P, et al. Respir Med. 2005 Dec;99 Suppl B:S11-8. doi: 10.1016/j.rmed.2005.09.011. Epub 2005 Oct 19. Respir Med. 2005. PMID: 16236492 Review. - The use of health status questionnaires in the management of chronic obstructive pulmonary disease patients in clinical practice.
van der Molen T, Diamant Z, Kocks JW, Tsiligianni IG. van der Molen T, et al. Expert Rev Respir Med. 2014 Aug;8(4):479-91. doi: 10.1586/17476348.2014.918851. Epub 2014 Jun 4. Expert Rev Respir Med. 2014. PMID: 24894492 Review.
Cited by
- Impact of pharmacist-led intervention in medication adherence and inhaler usage on asthma and chronic obstructive pulmonary disease control: a quasi-experimental study.
Adisa R, Ufuah UF, Ige OM. Adisa R, et al. BMC Health Serv Res. 2024 Oct 8;24(1):1199. doi: 10.1186/s12913-024-11683-9. BMC Health Serv Res. 2024. PMID: 39379970 Free PMC article. - Correlation of Parathyroid Hormone Values With Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease.
Zovko T, Galic K, Vasilj M, Pravdic N, Mikulic I, Mikulic V, Mandic A, Zovko S, Pravdic D. Zovko T, et al. Cureus. 2024 Jul 8;16(7):e64053. doi: 10.7759/cureus.64053. eCollection 2024 Jul. Cureus. 2024. PMID: 39114236 Free PMC article. - Evaluating the Effectiveness of the COPD Assessment Test (CAT) in Screening for Chronic Obstructive Pulmonary Disease.
Al Wachami N, Boumendil K, Arraji M, Iderdar Y, Mourajid Y, Ghosne N, Benmoussa A, Khalis M, Korrida A, Laamiri FZ, Lajane H, Louerdi ML, El Madani S, Chahboune M. Al Wachami N, et al. Int J Chron Obstruct Pulmon Dis. 2024 Jul 11;19:1623-1633. doi: 10.2147/COPD.S460649. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39011121 Free PMC article. - The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study.
Suri R, Markovic D, Woo H, Arjomandi M, Barr RG, Bowler RP, Criner G, Curtis JL, Dransfield MT, Drummond MB, Fortis S, Han MK, Hoffman EA, Kaner RJ, Kaufman JD, Krishnan JA, Martinez FJ, Ohar J, Ortega VE, Paine R 3rd, Soler X, Woodruff PG, Hansel NN, Cooper CB, Tashkin DP, Buhr RG, Barjaktarevic IZ. Suri R, et al. Am J Respir Crit Care Med. 2024 Nov 15;210(10):1210-1218. doi: 10.1164/rccm.202310-1965OC. Am J Respir Crit Care Med. 2024. PMID: 38507607 - TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life.
Richeldi L, Schino P, Bargagli E, Ricci A, Rocca A, Marchesani F, Pennisi A, Camiciottoli G, D'Amato M, Macagno F, Scaffidi Argentina U, Ingrassia E, Piraino A. Richeldi L, et al. Int J Chron Obstruct Pulmon Dis. 2024 Feb 23;19:475-487. doi: 10.2147/COPD.S445858. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38435125 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous